Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8547371 | 0.90 | PTGS2 (0.47) | PTGS2PTGS1TP53LMNATHRB | |
| SCHEMBL8546693 | 0.86 | PTGS2 (0.46) | PTGS2PTGS1TP53POLB | |
| SCHEMBL8552225 | 0.86 | PTGS2 (0.46) | PTGS2PTGS1TP53POLB | |
| SCHEMBL8547373 | 0.84 | PTGS2 (0.46) | PTGS2PTGS1TP53LMNATHRB | |
| SCHEMBL8546636 | 0.83 | PTGS2 (0.40) | PTGS2PTGS1TP53LMNATHRB | |
| SCHEMBL8551355 | 0.81 | PTGS2 (0.50) | PTGS2PTGS1 | |
| SCHEMBL8551030 | 0.80 | TP53 (0.43) | PTGS2PTGS1TP53LMNATHRB | |
| SCHEMBL8548972 | 0.80 | PTGS2 (0.42) | PTGS2PTGS1TP53 | |
| SCHEMBL8550177 | 0.80 | PTGS2 (0.42) | PTGS2PTGS1TP53LMNA | |
| SCHEMBL8615956 | 0.79 | PTGS2 (0.47) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0825989-A1 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-03-04 | — | — | EP | disclosed |